This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

IMS, Quintiles merger wins EU approval

( August 16, 2016, 10:08 GMT | Official Statement) -- MLex Summary: IMS Health Holdings and Quintiles Transnational Holdings — US-based data and services providers to the pharmaceutical industry — have received EU approval for their plans to merge. The overlap between the companies’ activities in the area of data collection based on actual patient experiences and clinical practice is very limited, the European Commission said. The commission therefore concluded that the deal raises no antitrust concerns.Mergers: Commission clears merger between IMS and Quintiles...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login